MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Data shows stability for up to 4 weeks.

Provenance

This compatibility recommendation is derived from Viread 245mg tablets (Gilead Sciences Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 2.5mg tablets (Bayer Plc).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 10mg tablets (Bayer Plc).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 15mg tablets (Bayer Plc).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 20mg tablets (Bayer Plc).

Stability Notes

The SPC states store in the original container to protect from moisture.

Provenance

This compatibility recommendation is derived from Resolor 1mg tablets (Takeda UK Ltd).

Stability Notes

SPC states store in the original container to protect from moisture.

Provenance

This compatibility recommendation is derived from Resolor 2mg tablets (Takeda UK Ltd).

Stability Notes

Airtight container. Protect from light.

Provenance

Compatiblity recommendation derived from Napp Pharmaceuticals Ltd product.

Stability Notes

Airtight container. Protect from light.

Provenance

Compatiblity recommendation derived from Napp Pharmaceuticals Ltd product.

Stability Notes

Airtight container. Protect from light.

Provenance

Compatiblity recommendation derived from Napp Pharmaceuticals Ltd product.

Stability Notes

There are no stability notes available for this medicine.
Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.